Skip to content
Menu

NRx Pharmaceuticals, Inc. NRXP

Full chart Compare
Set alert

Price alert · NRXP

All alert types
2.15 USD -0.40 (-15.69%)

Regular-session close

2.23 +0.08 +3.69%

After hours · Nov 20, 7:58 PM ET

2.14 Day range 2.53
1.68 52-week range 4.62
YTD
-20.66%
1 year
+5.91%

Held by funds

8 US ETFs and mutual funds hold NRXP · largest positions

  1. VTI 0.00% of fund $2.27M
  2. PSIL 4.15% of fund $1.51M
  3. VXF 0.00% of fund $1.10M
  4. FSMAX 0.00% of fund $600.68K
  5. IJE 0.02% of fund $280.36K
  6. IWC 0.02% of fund $260.98K
  7. VBINX 0.00% of fund $49.30K
  8. VITPX 0.00% of fund $35.09K

Ownership

  • Institutions 6.05%
  • Insiders 23.6%
  • Public and other holders 70.4%
Held by insiders 23.56%
Held by institutions 6.05%
Float held by institutions 7.92%
Institutions 21

Top institutional holders

Top institutional holders
Holder% heldSharesValueReported
Vanguard Group Inc1.99%240,316341.25KSep 29, 2024
Anson Funds Management LP1.18%142,525202.38KSep 29, 2024
AdvisorShares Investments, LLC1.08%130,085184.72KSep 29, 2024
Geode Capital Management, LLC0.64%77,341109.82KSep 29, 2024
Sabby Management, LLC0.29%35,04949.77KSep 29, 2024
Blackrock Inc.0.24%29,07541.29KSep 29, 2024

Top mutual fund holders

Top mutual fund holders
Holder% heldSharesValueReported
AdvisorShares Trust-AdvisorShares Psychedelics ETF2.41%291,271413.60KOct 30, 2024
Vanguard Total Stock Market Index Fund1.60%193,423274.66KSep 29, 2024
Vanguard Extended Market Index Fund0.39%46,89366.59KSep 29, 2024
Fidelity Extended Market Index Fund0.36%43,51061.78KOct 30, 2024
Fidelity Series Total Market Index Fund0.09%10,32714.66KOct 30, 2024
Fidelity Total Market Index Fund0.08%10,00514.21KOct 30, 2024

Included in Plus and up

Sign in to see Institutional ownership

How much funds own from their 13F filings, quarter by quarter, and the largest holders.

Free with an account

Sign in to see Insider activity

Two years of insider buying and selling by month, marked on the price.

Included in Plus and up

Sign in to see Congress trading

Every stock trade disclosed by members of the US Senate and House.

Leadership team

Who runs NRXP, and what each was last paid

Jonathan C. Javitt, Co-Founder, Chairman & CEOAverage age 67

NRXP key executives
NameTitlePayAge
Jonathan C. JavittCo-Founder, Chairman & CEO$718K 69
Michael S. AbramsCFO & Treasurer$363K 56
Riccardo PanicucciChief Manufacturing & Technology Officer$240K 64
Dennis K. McBrideChief Strategy Officer & Director$38.5K 72
Joseph CasperChief Operating Officer— 75
Michael TaylorChief Development Officer & Director— 51
Hervé PerronChief Scientist— 67
Philip T. LavinChief Methodologist— 79
Glenn TysonChief Commercial Officer— —
Joshua C. BrownChief Medical Innovation Officer— —
Suzanne MessereInvestor Relations— —

Pay is the latest total FMP has for each person (salary, bonus, stock and other awards) and can lag the newest proxy statement. Source: Financial Modeling Prep, from the company’s SEC filings.

Free with an account

Sign in to see CEO compensation

What the chief executive was paid each year, by salary, bonus and stock, beside the company's earnings.

Free with an account

Sign in to see Board of directors

Who sits on the board, who chairs it, and how long each director has served.

NRXP insiders
InsiderRelationLatest transactionDateShares held
GOROVITZ AARONDirectorPurchaseAug 29, 20230
HURVITZ CHAIMDirectorPurchaseAug 29, 20232,214,790
JAVITT JONATHAN CChairman of the BoardPurchaseDec 16, 20241,516,830